Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Clinical trial NCT02282215 · COMPLETED
Trial details
- NCT number
- NCT02282215
- Sponsor
- Cellerant Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-09-22
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.